415 related articles for article (PubMed ID: 25036814)
21. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
Guo XF; Yang B; Tang J; Li D
Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
[TBL] [Abstract][Full Text] [Related]
22. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
[TBL] [Abstract][Full Text] [Related]
23. Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction.
Eussen SR; Geleijnse JM; Giltay EJ; Rompelberg CJ; Klungel OH; Kromhout D
Eur Heart J; 2012 Jul; 33(13):1582-8. PubMed ID: 22301766
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Kwak SM; Myung SK; Lee YJ; Seo HG;
Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407
[TBL] [Abstract][Full Text] [Related]
25. The ratio of eicosapentaenoic acid to docosahexaenoic acid as a modulator for the cardio-metabolic effects of omega-3 supplements: A meta-regression of randomized clinical trials.
AbuMweis S; Abu Omran D; Al-Shami I; Jew S
Complement Ther Med; 2021 Mar; 57():102662. PubMed ID: 33418065
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Omega-3 Fatty Acids, EPA, and/or DHA on Male Infertility: A Systematic Review and Meta-analysis.
Hosseini B; Nourmohamadi M; Hajipour S; Taghizadeh M; Asemi Z; Keshavarz SA; Jafarnejad S
J Diet Suppl; 2019; 16(2):245-256. PubMed ID: 29451828
[TBL] [Abstract][Full Text] [Related]
27. No effect of omega-3 polyunsaturated fatty acid supplementation on inflammatory markers in familial hypercholesterolemia: a randomized crossover trial.
Hande LN; Thunhaug H; Ludviksen J; Hovland A; Lappegård KT
Scand J Clin Lab Invest; 2023 May; 83(3):152-159. PubMed ID: 36999528
[TBL] [Abstract][Full Text] [Related]
28. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
Rizos EC; Ntzani EE; Bika E; Kostapanos MS; Elisaf MS
JAMA; 2012 Sep; 308(10):1024-33. PubMed ID: 22968891
[TBL] [Abstract][Full Text] [Related]
29. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials.
Zhang B; Zhen Y; Tao A; Bao Z; Zhang G
J Cardiol; 2014 Jan; 63(1):53-9. PubMed ID: 23911138
[TBL] [Abstract][Full Text] [Related]
30. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38869144
[TBL] [Abstract][Full Text] [Related]
31. Recent Clinical Trials Shed New Light on the Cardiovascular Benefits of Omega-3 Fatty Acids.
Kris-Etherton PM; Richter CK; Bowen KJ; Skulas-Ray AC; Jackson KH; Petersen KS; Harris WS
Methodist Debakey Cardiovasc J; 2019; 15(3):171-178. PubMed ID: 31687095
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 Polyunsaturated Fatty Acid Supplementation to Prevent Arteriovenous Fistula and Graft Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Viecelli AK; Irish AB; Polkinghorne KR; Hawley CM; Johnson DW; Mori TA; Pascoe EM; Strippoli GFM; Lok CE; Palmer SC
Am J Kidney Dis; 2018 Jul; 72(1):50-61. PubMed ID: 29395485
[TBL] [Abstract][Full Text] [Related]
33. Omega-3 (
Djuricic I; Calder PC
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612996
[TBL] [Abstract][Full Text] [Related]
34. Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting.
Schmöcker C; Zhang IW; Kiesler S; Kassner U; Ostermann AI; Steinhagen-Thiessen E; Schebb NH; Weylandt KH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316682
[TBL] [Abstract][Full Text] [Related]
35. Which polyunsaturated fatty acids are active in children with attention-deficit hyperactivity disorder receiving PUFA supplementation? A fatty acid validated meta-regression analysis of randomized controlled trials.
Puri BK; Martins JG
Prostaglandins Leukot Essent Fatty Acids; 2014 May; 90(5):179-89. PubMed ID: 24560325
[TBL] [Abstract][Full Text] [Related]
36. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
Welty FK; Daher R; Garelnabi M
Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
[TBL] [Abstract][Full Text] [Related]
37. Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials.
Saglimbene VM; Wong G; van Zwieten A; Palmer SC; Ruospo M; Natale P; Campbell K; Teixeira-Pinto A; Craig JC; Strippoli GFM
Clin Nutr; 2020 Feb; 39(2):358-368. PubMed ID: 30905498
[TBL] [Abstract][Full Text] [Related]
38. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
[TBL] [Abstract][Full Text] [Related]
39. Omega-3 fatty acids for cardioprotection.
Lee JH; O'Keefe JH; Lavie CJ; Marchioli R; Harris WS
Mayo Clin Proc; 2008 Mar; 83(3):324-32. PubMed ID: 18316000
[TBL] [Abstract][Full Text] [Related]
40. Aspirin and omega-3 polyunsaturated fatty acid use and their interaction in cardiovascular diseases and colorectal adenomas.
Wang IE; Yi S; Block RC; Mousa SA
Nutr Res Rev; 2022 Dec; 35(2):295-307. PubMed ID: 34253265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
